Urothelial carcinoma and the potential clinical application of urinary extracellular vesicles: Current Status and prospects [0.03%]
尿路上皮癌和尿液外泌体潜在临床应用现状及前景展望
Eisuke Tomiyama,Fumihiko Urabe,Kazutoshi Fujita et al.
Eisuke Tomiyama et al.
Background: Recently, urinary extracellular vesicles (uEVs) have emerged as promising biomarkers for early diagnosis, prognosis, and treatment monitoring in urothelial carcinoma (UC). uEVs encapsulate nucleic acids, prote...
Can urinary tumor DNA be used to assess the risk of recurrence in patients with non-muscle invasive bladder cancer? [0.03%]
尿液肿瘤DNA能否用于评估非肌层浸润性膀胱癌患者的复发风险？
Kamil Malshy,Edward M Messing
Kamil Malshy
Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications [0.03%]
尿路上皮癌中mRNA剪接失调的临床、诊断和治疗意义
Rod Carlo A Columbres,Andrea B Apolo,A Rouf Banday
Rod Carlo A Columbres
Alterations in mRNA splicing play a critical role in driving the molecular heterogeneity of many cancers, including urothelial carcinoma, by contributing to disease progression, treatment response, and clinical outcomes. These splicing chan...
Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer [0.03%]
《膀胱癌杂志》成为IBCN官方伙伴，加强全球膀胱癌防治合作
Lars Dyrskjøt,Peter Black,Seth Lerner et al.
Lars Dyrskjøt et al.
When a 'routine' TURBT is not routine: Lessons from SEER-medicare [0.03%]
当"TURBT常规" 并非真正常规时的教训——来自SEER- medicare的启示
Kamil Malshy,Edward M Messing
Kamil Malshy
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank [0.03%]
来自英国生物样本库的证据：膀胱癌的遗传易感性和环境危险因素
Laura Bukavina,Ilaha Isali,Sneha Parekh et al.
Laura Bukavina et al.
Purpose: This study aims to identify specific genotypes within the UK Biobank (UKB) cohort contributing to a genetic predisposition for bladder cancer (UBC). It highlighted the impact of environmental exposures and the br...
Impact of lymphovascular invasion and histological variants on BCG-treated high-grade NMIBC prognosis [0.03%]
淋巴管侵犯和组织学亚型对BCG治疗失败的高危NMIBC预后的影响分析
Ali Nebioğlu,Mert Başaranoğlu,Murat Bozlu et al.
Ali Nebioğlu et al.
Purpose: This study aimed to evaluate the impact of lymphovascular invasion (LVI) and histologic subtypes on prognosis following Bacillus Calmette-Guérin (BCG) therapy in high-grade non-muscle invasive bladder cancer (NM...
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer [0.03%]
基于基因表达的膀胱癌淋巴结转移预测模型的效果评估
Hafdís Birta Johansson,Fredrik Liedberg,Carina Bernardo et al.
Hafdís Birta Johansson et al.
Background: The presence of cancer in pelvic lymph nodes removed during radical surgery for muscle-invasive bladder cancer (MIBC) is a key determinant of patient outcome. It would be beneficial to predict node status preoperatively to tailo...
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management [0.03%]
膀胱小细胞癌：发病机制、临床表现及治疗进展的文献复习
Nicholas I Simon,Andre R Kydd,Dilara Akbulut et al.
Nicholas I Simon et al.
Small cell carcinoma of the bladder (SCCB) is a rare, aggressive malignancy that accounts for less than 1% of all bladder cancers. In this report, we highlight the clinical manifestations of SCCB (including epidemiology, cystoscopic and ima...
Tine Ginnerup Andreasen,Trine Strandgaard,Line Raaby et al.
Tine Ginnerup Andreasen et al.
Background: The recommended treatment for high-risk non-muscle invasive bladder cancer (NMIBC) is intravesical instillations of Bacillus Calmette-Guérin (BCG). Despite completing BCG therapy, up to 40% of patients experi...